GH Guardant Health, Inc.
Data as of close
Healthcare · Services-Medical Laboratories
Guardant Health, Inc. (GH) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $23.5 billion. Shares last traded at $174.99, 8.4% below their 52-week high. Over the past year the stock is up 88.1%. Net profit margin is -38.3%, below the peer median of -5.4%. Revenue grew 32.9% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | -$0.90 | 2026-07-30 |
| Q1 2026 | -$0.85 | 2026-05-07 |
| Q4 2025 (derived) | -$1.01 | 2026-02-19 |
| FY 2025 | -$3.32 | 2026-02-19 |
| Q3 2025 | -$0.74 | 2025-10-29 |
| Q2 2025 | -$0.80 | 2025-07-30 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Services-Medical Laboratories peers
GH vs 14 industry peers (Services-Medical Laboratories), by market cap. Data as of close
| NTRA | Natera, Inc. | $56.0B | — | 20.69 | -7.1% | +2.52% |
| LH | Labcorp | $28.7B | 28.62 | 1.97 | 6.9% | -0.52% |
| DGX | Quest Diagnostics | $27.2B | 24.07 | 2.29 | 9.5% | -1.51% |
| GH | Guardant Health, Inc. | $23.5B | — | 19.85 | -38.3% | +2.41% |
| CAI | Caris Life Sciences, Inc. | $9.3B | 88.30 | 9.38 | 10.6% | +2.37% |
| GRAL | Grail, Inc. | $6.2B | — | — | — | +4.36% |
| RDNT | Radnet, Inc. | $5.8B | — | 2.54 | -0.9% | +0.17% |
| BLLN | Billiontoone, Inc. | $5.2B | 138.14 | 13.11 | 9.5% | +0.04% |
| CDNA | Caredx, Inc. | $4.7B | 36.15 | 9.35 | 25.9% | +3.04% |
| VCYT | Veracyte, Inc. | $4.0B | 35.31 | 7.19 | 20.4% | +2.52% |
| CELC | Celcuity Inc. | $3.4B | — | — | — | +3.88% |
| FTRE | Fortrea Holdings Inc. | $2.0B | — | 0.76 | -2.6% | +4.75% |
| PSNL | Personalis, Inc. | $1.7B | — | — | — | +0.00% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | — | — | — | +0.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.